Wegovy Reduces Risk of Stroke and Heart Attacks, According to Company

  • 📰 NBCNews
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 86%

Business News News

Business Business Latest News,Business Business Headlines

The obesity drug Wegovy cuts the risk of cardiovascular events such as heart attack and stroke by 20%, drugmaker Novo Nordisk says.

The results may be compelling enough to get insurance companies to provide coverage, said Dr. Shauna Levy, a specialist in obesity medicine and the medical director of the Tulane Bariatric Center in New Orleans.

“Twenty percent is huge,” Levy said. “All of this narrative about people just wanting this for cosmetic reasons, I think, to some degree, has overshadowed all of the health benefits we can get from this medication.”The findings were based on a late-stage clinical trial of more than 17,000 adults ages 45 and up who got a 2.4-milligram dose of Wegovy or a placebo in addition to standard care.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 10. in BUSİNESS

Business Business Latest News, Business Business Headlines